Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » Education » Book Chapters » Focus on Colorectal Cancer Research » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
_Cancer Research Journal - This journal ceased publication after 4#4 (2010). Back Issues are available.
$195.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Bestsellers
01.Molecular Pathogenesis Of Colorectal Cancer: Implications For Molecular Diagnosis (pp. 1-23)
02.Role Of Phytochemicals In Colon Carcinogenesis (pp. 41-64)
03.Treatment Of Advanced Colorectal Cancer: Current Status And Future Perspectives (pp. 171-208)
Notifications more
NotificationsNotify me of updates to Treatment Of Advanced Colorectal Cancer: Current Status And Future Perspectives (pp. 171-208)
Tell A Friend
 
Tell someone you know about this product.
Treatment Of Advanced Colorectal Cancer: Current Status And Future Perspectives (pp. 171-208) $25.00
Authors:  Grivicich, I.; da Rocha, A. B.; Peters, G. J.; Schwartsmann, G, ( VU University Medical Center, Amsterdam, The Netherlands;Universidade Luterana do Brasil, Porto Alegre, Brazil)
Abstract:
Colorectal cancer is a common disease with high rate of mortality and very well understood genetics. The majority of patients are diagnosed in an advanced stage of the disease, thus requiring chemotherapy. The prognosis and treatment modality for advanced colorectal cancer depends on the tumor stage, since the accumulation of molecular alterations has been commonly associated with poor prognosis and treatment failure. Although there is evidence of benefit of chemotherapy in adjuvant and metastatic settings, its use still remains unsatisfactory because of intrinsic or acquired drug resistance. The most commonly used protocols in advanced colorectal carcinoma include the antimetabolite 5-fluorouracil (5-FU). Several effective alternative treatment options became available for patients with colorectal cancer who relapse after a 5-FU-based chemotherapy. The introduction of irinotecan and oxaliplatin to the therapy with 5- FU/leucovorin has contributed to increase therapeutic options and to improve response rates and survival. The development of oral agents broadened the treatment options available for patients with this disease. Based on the diversity of molecular behavior of advanced colorectal cancer, a number of new agents entered clinical trials. Among others, cyclooxygenase-2 inhibitors, vascular endothelial growth inhibitors and epidermal growth factor inhibitors, are under investigation. Furthermore, the knowledge of the genetics characteristics can be useful to identify prognostic differences, tumor molecular staging and patient stratification, leading to elect a better treatment modality. 


Available Options:
Version:
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2021

Treatment Of Advanced Colorectal Cancer: Current Status And Future Perspectives (pp. 171-208)